Quality to rely on: meeting report of the 5th Meeting of External Quality Assessment, Naples 2016

Por van Krieken, Han, Deans, Sandi, Hall, Jacqueline A, Normanno, Nicola, Ciardiello, Fortunato, Douillard, Jean-Yves
Publicado no ESMO Open (2016)

Specific CDK4/6 inhibition in breast cancer: a systematic review of current clinical evidence

Por Polk, Anne, Kolmos, Ida Lykke, Kümler, Iben, Nielsen, Dorte Lisbeth
Publicado no ESMO Open (2017)

Prevalence of hypothyroidism among patients with breast cancer treated with radiation to the supraclavicular field: a single-centre survey

Por Kikawa, Yuichiro, Kosaka, Yasuhiro, Hashimoto, Kazuki, Hohokabe, Eri, Takebe, Sayaka, Narukami, Ryo, Hattori, Takayuki, Ueki, Kazuhiro, Ogura, Kengo, Imagumbai, Toshiyuki, Kato, Hironori, Kokubo, Masaki
Publicado no ESMO Open (2017)

Impact of intervention aimed at improving the integration of oncology units and local palliative care services: results of the multicentre prospective sequential MIRTO study

Por Martoni, Andrea A, Melotti, Barbara, Degli Esposti, Claudia, Mutri, Vita, Lelli, Giorgio, Ansaloni, Silvia, Piva, Erico, Strocchi, Elena, Pannuti, Franco
Publicado no ESMO Open (2017)

European Medicines Agency approval summary: Zaltrap for the treatment of patients with oxaliplatin-resistant metastatic colorectal cancer

Por Stanel, Stefan Cristian, Sjöberg, Jan, Salmonson, Tomas, Foggi, Paolo, Caleno, Mariapaola, Melchiorri, Daniela, Gravanis, Iordanis, Tzogani, Kyriaki, Pignatti, Francesco
Publicado no ESMO Open (2017)

Lactobacillus brevis CD2 lozenges prevent oral mucositis in patients undergoing high dose chemotherapy followed by haematopoietic stem cell transplantation

Por Sharma, Atul, Tilak, TVSVGK, Bakhshi, Sameer, Raina, Vinod, Kumar, Lalit, Chaudhary, Surendra Pal, Sahoo, Ranjit Kumar, Gupta, Ritu, Thulkar, Sanjay
Publicado no ESMO Open (2017)

Erlotinib intercalating pemetrexed/cisplatin versus erlotinib alone in Chinese patients with brain metastases from lung adenocarcinoma: a prospective, non-randomised, concurrent co...

Por Yang, Haihong, Deng, Qiuhua, Qiu, Yuan, Huang, Jun, Guan, Yubao, Wang, Fengnan, Xu, Xin, Yang, Xinyun
Publicado no ESMO Open (2017)

From precision medicine to cancer care through the immunome: highlights from the European Society of Medical Oncology Congress, Madrid, 26–30th September 2014

Por Curigliano, Giuseppe
Publicado em 2014

Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies: a machine learning approach

Por Lin, Frank P. Y., Pokorny, Adrian, Teng, Christina, Dear, Rachel, Epstein, Richard J.
Publicado no BMC Cancer (2016)

Clonal evolution and KRAS-MET coamplification during secondary resistance to EGFR-targeted therapy in metastatic colorectal cancer

Por Sartore-Bianchi, Andrea, Valtorta, Emanuele, Amatu, Alessio, Veronese, Silvio, Lauricella, Calogero, Bonazzina, Erica, Siravegna, Giulia, Truini, Mauro, Bardelli, Alberto, Siena, Salvatore
Publicado no ESMO Open (2016)

Time since start of first-line therapy as a predictive clinical marker for nintedanib in patients with previously treated non-small cell lung cancer

Por Gaschler-Markefski, Birgit, Sikken, Patricia, Heymach, John V, Gottfried, Maya, Mellemgaard, Anders, Novello, Silvia, Gann, Claudia-Nanette, Barrueco, José, Reck, Martin, Hanna, Nasser H, Kaiser, Rolf
Publicado no ESMO Open (2017)

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer

Por Kitano, Atsuko, Ono, Makiko, Yoshida, Masayuki, Noguchi, Emi, Shimomura, Akihiko, Shimoi, Tatsunori, Kodaira, Makoto, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Kinoshita, Takayuki, Fujiwara, Yasuhiro, Tsuda, Hitoshi, Tamura, Kenji
Publicado no ESMO Open (2017)

A consensus on liquid biopsy from the 2016 Chinese Lung Cancer Summit expert panel

Por Wu, Yi-Long, Wang, Chang-Li, Sun, Yan, Liao, Mei-Lin, Guan, Zhong-Zhen, Yang, Zhi-Min, Zhou, Qing-Hua, Lu, Shun, Cheng, Ying, Liu, Xiao-Qing, Zhang, Xu-Chao, Zhou, Caicun, Wang, Jie, Zhou, Qing, Song, Yong, Han, Bao-Hui, Ma, Zhi-Yong, Yang, Fan, Wang, Qun, Chuai, Shao-Kun, Shao, Yang, He, Wei, Zhu, Guanshan, Xiong, Lei, Wang, Jian-Jun, Chen, Ke-Neng, Zhang, Li, Mao, Wei-Min, Ma, Sheng-Lin, Feng, Ji-Feng, Yang, Xue-Ning, Xu, Lin, Chen, Gang, Zhao, Jian, Song, Qi-Bin, SHEN-TU, Yang, Qiao, Gui-Bin, Yu, Ding, Yu, Shi-Ying, Hu, Yi, Chen, Ming, Chen, Gong-Yan, Fan, Yun, Zhang, He-Long, Liang, Jun, Zhu, Guang-Ying, Cui, Jiu-Wei, Yang, Jin-Ji, Zhao, Qiong, Zhao, Ming-Fang, Lu, You, Chang, Jian-Hua, Li, Jun-Ling, Yang, Yue, Hu, Jie, Gu, Chun-Dong, Zhang, Yi-Chen, Zhong, Wen-Zhao
Publicado no ESMO Open (2017)

Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

Por Patil, Vijay Maruti, Noronha, Vanita, Joshi, Amit, Choughule, Anuradha Bharat, Bhattacharjee, Atanu, Kumar, Rajiv, Goud, Supriya, More, Sucheta, Ramaswamy, Anant, Karpe, Ashay, Pande, Nikhil, Chandrasekharan, Arun, Goel, Alok, Talreja, Vikas, Mahajan, Abhishek, Janu, Amit, Purandare, Nilendu, Prabhash, Kumar
Publicado no ESMO Open (2017)

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna

Por Kiesewetter, Barbara, Raderer, Markus, Steger, Günther G, Bartsch, Rupert, Pirker, Robert, Zöchbauer-Müller, Sabine, Prager, Gerald, Krainer, Michael, Preusser, Matthias, Schmidinger, Manuela, Zielinski, Christoph C
Publicado no ESMO Open (2016)

Phase I study of neoadjuvant chemotherapy with S-1 and oxaliplatin for locally advanced gastric cancer (Neo G-SOX PI)

Por Satake, Hironaga, Miki, Akira, Kondo, Masato, Kotake, Takeshi, Okita, Yoshihiro, Hatachi, Yukimasa, Yasui, Hisateru, Imai, Yukihiro, Ichikawa, Chihiro, Murotani, Kenta, Hashida, Hiroki, Kobayashi, Hiroyuki, Kotaka, Masahito, Kato, Takeshi, Kaihara, Satoshi, Tsuji, Akihito
Publicado no ESMO Open (2017)

Recent developments and translational aspects in targeted therapy for metastatic breast cancer

Por Marhold, Maximilian, Bartsch, Rupert, Zielinski, Christoph
Publicado no ESMO Open (2016)

KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapy

Por Ambrogio, Chiara, Nadal, Ernest, Villanueva, Alberto, Gómez-López, Gonzalo, Cash, Timothy P, Barbacid, Mariano, Santamaría, David
Publicado no ESMO Open (2016)

CECOG educational illustrations: the blood–brain barrier and its relevance for targeted cancer therapies and immuno-oncology

Por Preusser, Matthias, Berghoff, Anna S, Thallinger, Christiane, Zielinski, Christoph
Publicado no ESMO Open (2017)

Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST s...

Por Hagiwara, Yasuhiro, Ohashi, Yasuo, Okusaka, Takuji, Ueno, Hideki, Ioka, Tatsuya, Boku, Narikazu, Egawa, Shinichi, Hatori, Takashi, Furuse, Junji, Mizumoto, Kazuhiro, Ohkawa, Shinichi, Yamaguchi, Taketo, Yamao, Kenji, Funakoshi, Akihiro, Cheng, Ann-Lii, Kihara, Kiyohiro, Sato, Atsushi, Tanaka, Masao
Publicado no ESMO Open (2017)